IMMEDIATE NEWS RELEASE
November 26th 2007
BioPharma Systems signs North American sales agreement with
Telstar Life Science Division
On November 26th, BioPharma Systems, Springhouse PA,
agreed to exclusively represent an extensive range of clean air, containment
and aseptic/sterilization products from Telstar Life Science, a division of Telstar.
BioPharma Systems is a recently formed collaboration
between Mark
Walkush and David Pallister, (formerly Extract Technology ltd.) to provide high quality technical sales support to our
North American client base across a variety of Pharmaceutical and Biotech
arenas including containment, aseptic processing, laminar flow/clean air
technology, sterilization and filling systems.
Our company has a combined 25+ years of experienced
support to the industry in matters relating to upfront design, sourcing, and
scoping a variety of systems not to mention value added integration of OEM
components into our established range of products.
We feel that the BioPharma Systems partnership
with the Telstar Life Science Division including the technology brand Telstar
ACE (Applied Containment Engineering), thru its European and US support will
provide our US client base with high quality solutions thru custom and standard
product offerings engineered to suit all project requirements backed with
validation documentation and field service/startup.
An important fact behind the decision by BioPharma
Systems to enter into the Telstar Life Science agreement was in Telstar’s
ability for
·
Containment solutions including isolators and
airflow protection.
·
Aseptic processing solutions.
·
Laminar flow systems
·
BioSafety Cabinets.
·
Sterilization products.
·
Custom filling solutions
BioPharma Systems looks forward to servicing our clients,
principal partners and agent network throughout North America,
Contact:
BioPharma Systems
T: 888 554 5885
David
Pallister Mark
Walkush
T:
919 791 1965 T:
215 272 2522
E-mail:
dpallister@b-psystems.com E-mail:
mwalkush@b-psystems.com